These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 38392966)

  • 1. Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD.
    Nakashima M; Suga N; Ikeda Y; Yoshikawa S; Matsuda S
    Noncoding RNA; 2024 Feb; 10(1):. PubMed ID: 38392966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
    Zhang Y; Xu Y; Bao Y; Luo Y; Qiu G; He M; Lu J; Xu J; Chen B; Wang Y
    Epigenetics; 2023 Dec; 18(1):2260213. PubMed ID: 37766615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.
    Li R; Zhu C; Wang Y; Wang X; Wang Y; Wang J; Wang K
    Cell Death Dis; 2024 Apr; 15(4):275. PubMed ID: 38632251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells.
    Dou Z; Ma XT; Piao MN; Wang JP; Li JL
    Transl Cancer Res; 2024 Jun; 13(6):3106-3125. PubMed ID: 38988908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
    Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
    Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ramifications of m6A Modification on ncRNAs in Cancer.
    Mehmood R
    Curr Genomics; 2024 May; 25(3):158-170. PubMed ID: 39087001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.
    Han J; Kong H; Wang X; Zhang XA
    Cell Prolif; 2022 Oct; 55(10):e13294. PubMed ID: 35735243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between m6A and ncRNAs and Its Association with Diseases.
    Chen S; Dong J; Luo X; Nie Z; Lu S; Liu H; Liu J
    Cytogenet Genome Res; 2022; 162(4):171-187. PubMed ID: 36122561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
    Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
    Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between circRNAs and m6A modifications in solid tumors.
    Liu F; Gu W; Shao Y
    J Transl Med; 2024 Jul; 22(1):694. PubMed ID: 39075555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications.
    Liu Z; Gao L; Cheng L; Lv G; Sun B; Wang G; Tang Q
    Exp Mol Med; 2023 Mar; 55(3):487-501. PubMed ID: 36854773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel insights into the interaction between N6-methyladenosine modification and circular RNA.
    Xu T; He B; Sun H; Xiong M; Nie J; Wang S; Pan Y
    Mol Ther Nucleic Acids; 2022 Mar; 27():824-837. PubMed ID: 35141044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
    Lin H; Wang Y; Wang P; Long F; Wang T
    Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
    Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
    Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology.
    Wu J; Guo X; Wen Y; Huang S; Yuan X; Tang L; Sun H
    Front Cell Dev Biol; 2021; 9():709299. PubMed ID: 34368159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA.
    Zhang Z; Wei W; Wang H; Dong J
    Front Oncol; 2021; 11():743990. PubMed ID: 34722298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues.
    Meng Q; Schatten H; Zhou Q; Chen J
    Aging (Albany NY); 2023 Jul; 15(13):6577-6619. PubMed ID: 37437245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer.
    Hu X; Lei X; Guo J; Fu W; Sun W; Lu Q; Su W; Xu Q; Tu K
    Front Oncol; 2022; 12():927640. PubMed ID: 35936737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.
    Wang D; Han Y; Peng L; Huang T; He X; Wang J; Ou C
    Int J Biol Sci; 2023; 19(7):2198-2219. PubMed ID: 37151887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-methyladenosine methylation mediates non-coding RNAs modification in microplastic-induced cardiac injury.
    Zhang M; Shi J; Zhou J; Song L; Ding J; Deng HP; Weng L; Zhu Y; Xu Z
    Ecotoxicol Environ Saf; 2023 Jun; 262():115174. PubMed ID: 37354568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.